Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Cannapharmarx (CPMD) Stock Price & Analysis

CPMD Stock Chart & Stats

$0.00-$0.00(-4.76%)
At close: 3:07 PM EDT
$0.01$0.0105$0.01119 Aug5 Sep20 Sep27 Sep17 Oct29 Oct12 Nov
Day’s Range
$0.01 - $0.01
52-Week Range
N/A
Previous Close
$0.01
Volume
N/A
Average Volume (3M)
217.46K
Market Cap
$1.42M
Enterprise Value
$22.67T
Total Cash (Recent Filing)
$555
Total Debt (Recent Filing)
$20.63M
Price to Earnings (P/E)
―
Beta
-0.16
Next Earnings
May 25, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Rapid revenue growth indicates improving commercial traction and customer adoption. Although growth comes from a small base, continued expansion could strengthen the operating platform if the company converts sales into healthier gross margins.

Improving Cash Flow

The shift from negative to modestly positive operating and free cash flow suggests improved working-capital management or lower cash burn. Sustained cash generation would reduce reliance on external funding and support operational continuity.

Reduced Cash Burn

Improved cash discipline is a constructive operational signal because it may provide management with more time to address weak profitability. If maintained through cost control, it could improve financial resilience even before earnings turn positive.

Bears Say

Persistent Negative Equity

A persistent equity deficit indicates accumulated losses have overwhelmed the capital structure. This weakens financial flexibility, limits access to conventional financing and increases the likelihood of dilution or restructuring over the medium term.

Severe Unprofitability

Negative gross profit and losses that exceed revenue point to fundamentally unsustainable unit economics and a heavy cost structure. Revenue growth alone may not create value unless pricing, production economics and operating expenses improve materially.

Refinancing Dependence

Significant debt combined with negative equity increases refinancing risk and reduces room to absorb setbacks. Continued operations may require additional capital, exposing shareholders to dilution and the business to higher funding constraints.

Cannapharmarx News

CPMD FAQ

What is Cannapharmarx’s market cap?
Cannapharmarx’s market cap is $1.42M.
When is Cannapharmarx’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cannapharmarx’s earnings last quarter?
Cannapharmarx released its earnings results on May 19, 2026. The company reported -$0.001 earnings per share for the quarter.
Is Cannapharmarx overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Cannapharmarx pay dividends?
Cannapharmarx does not currently pay dividends.
What is Cannapharmarx’s EPS estimate?
Cannapharmarx’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannapharmarx have?
Cannapharmarx has 708,689,900 shares outstanding.
What happened to Cannapharmarx’s price movement after its last earnings report?
Cannapharmarx reported an EPS of -$0.001 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cannapharmarx?
Currently, no hedge funds are holding shares in CPMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology